Pohlaw.org: A Living Archive at the Intersection of Scientific History and Legal Education
We are an independent editorial team committed to preserving and interpreting the long heritage of this domain—one that has always stood at the crossroads where rigorous scientific inquiry meets the evolving framework of law and public accountability. Our work is not about building a case; it is about building understanding. Here, readers will find carefully curated reference materials, detailed timelines, and educational analysis that illuminate how scientific discoveries, regulatory actions, and legal doctrines have shaped—and continue to shape—some of the most consequential issues of our time.
Our audience includes researchers, journalists, policy analysts, students, and engaged citizens who seek objective, well-sourced context rather than advocacy. Whether you are exploring the chemistry behind a pharmaceutical compound’s degradation, the history of a federal safety investigation, or the procedural path of mass tort litigation, our archive offers a stable foundation. We do not provide legal advice, offer claim screening, or match readers with attorneys. Instead, we provide the informational framework that allows individuals to navigate complex subjects with greater clarity.
Comprehensive Reference Material on Medical‑Legal Scientific History
The heart of our editorial mission lies in assembling reference material that connects the laboratory bench to the courtroom. We draw from peer‑reviewed studies, internal corporate documents released through discovery, regulatory filings from agencies such as the FDA and EPA, and trial transcripts to construct a factual record that stands independent of any single party’s interest. For example, our detailed guide on Zantac cancer lawsuit claims and the scientific timeline of NDMA formation weaves together analytical chemistry data, epidemiological evidence, and the chronological sequence of regulatory and legal responses. This resource is emblematic of our approach: we present the science as it emerged, the regulatory decisions as they happened, and the legal claims as they were filed—all without editorializing on the merits of any individual case.
Each reference entry we publish includes citations to primary sources, links to freely available full‑text documents where possible, and notes on conflicting interpretations. We believe that transparency about our own sources is essential to maintaining the trust of readers who may use this information for academic research, journalistic investigation, or personal education. Our library now spans topics from pharmaceutical liability and environmental toxicology to historical patent disputes and the evolution of product‑liability doctrine.
Timelines That Illuminate Cause, Effect, and Accountability
One of our flagship features is the construction of detailed, annotated timelines that trace the chain of events behind major medical‑legal controversies. These timelines are not simple lists of dates; they are narrative threads that show how a scientific anomaly noted in a single study can lead, over years or decades, to a wave of litigation, a regulatory overhaul, and sometimes a change in clinical practice. The Zantac (ranitidine) story is a prime example: from the first characterization of N‑nitrosodimethylamine (NDMA) as a probable human carcinogen, to the discovery of its instability in ranitidine formulations, to the eventual market withdrawal and consolidation of thousands of lawsuits. Our timeline for that topic connects the key experiments, FDA alerts, internal company memos, and court rulings in a sequence that helps readers grasp the interplay of science and law without oversimplification.
We extend this timeline methodology to other domains as well—including vaccine‑injury litigation, environmental contamination cases, and medical device failures. Each timeline is reviewed for accuracy by our editorial board, which includes contributors with backgrounds in chemistry, pharmacology, and legal history. We do not claim that our timelines are exhaustive, but we strive to make them as reliable and useful as possible for anyone seeking a map of a complex landscape.
An Educational Resource for Researchers, Journalists, and the Public
Our scope is deliberately educational. We recognize that the language of science—parts per billion, half‑life, confidence intervals—can be as foreign to a lay reader as legal terms of art like “statute of repose” or “joint and several liability.” A core part of our mission is to translate these concepts into accessible prose without losing precision. To that end, we include glossaries, explanatory sidebars, and cross‑references that allow readers to move from a basic overview to deep technical analysis at their own pace.
We also maintain a section devoted to the history of this domain itself. The name “pohlaw.org” evokes a tradition of examining how formal legal systems react to—and sometimes struggle to keep up with—scientific advancement. We honor that tradition by remaining independent of any law firm, advocacy organization, or commercial interest. Our funding comes from institutional grants and reader contributions, and our editorial decisions are made without external influence. In 2026, as we continue to expand our archive, we remain dedicated to the principle that informed public discourse requires reliable, freely accessible reference materials. This homepage is not an index or a portal; it is an invitation to explore a living repository where history, science, and law intersect—and where understanding, not advocacy, is the only goal.
From this context, claimants should organize records, treatment chronology, and exposure evidence before legal intake. Compliance terms: FDA; statute of limitations; class action; MDL; mass tort; plaintiff; settlement; adverse event; litigation; compensation.